The aim of this study is to investigate the long-term prognosis for glaucoma in patients with Posner–Schlossman syndrome (PSS).
In this retrospective case series study, a total of 98 patients with PSS from January 2014 to February 2019 were included in this study. Initial presentations and follow-up data were obtained from medical records. Vision-related quality of life (VR-QoL) was assessed using the 25-item National Eye Institute Visual Functioning Questionnaire.
Of the 98 patients included in the study, 66 (67%) presented with glaucoma, and among them, 21 (32%) required glaucoma surgery. The mean follow-up time was 50.1 months (range 1–263 months). Iris involvement was noted in 46 (46.9%) eyes; 26 (26.5%) had sectoral iris changes and 20 (20.4%) showed diffuse iris changes. Eyes with iris involvement had a significantly higher number of acute attacks of uveitis than those without (p = 0.010). The 5-year glaucoma surgery-free interval was 77.8% according to Kaplan–Meier analysis. Significant predictors of glaucoma surgery included iris involvement (hazard ratio [HR] = 5.215; confidence interval [CI] = 1.387–19.610), highest number of anti-glaucoma agents (HR = 5.069; CI = 1.848–13.905), baseline average retinal nerve fiber layer thickness (RNFLT) thickness (HR = 0.949; CI = 0.917–0.982), and disease duration (HR = 0.977; CI = 0.957–0.996). Overall complete surgical success and qualified success at 2 years was 35.3% and 75.5%, respectively. Patients with iris involvement, glaucoma surgery, and thinner average RNFLT had significantly poorer VR-QoL (all, p < 0.05).
Patients with PSS and glaucoma required glaucoma surgery in a high rate. Iris involvement increased the probability of surgical treatment and lowered the VR-QoL of PSS patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Acharya NR, Tham VM, Esterberg E, Borkar DS, Parker JV, Vinoya AC, Uchida A (2013) Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol 131:1405–1412. https://doi.org/10.1001/jamaophthalmol.2013.4237
Takase H, Kubono R, Terada Y, Imai A, Fukuda S, Tomita M, Miyanaga M, Kamoi K, Sugita S, Miyata K, Mochizuki M (2014) Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol 58:473–482. https://doi.org/10.1007/s10384-014-0340-6
Megaw R, Agarwal PK (2017) Posner-Schlossman syndrome. Surv Ophthalmol 62:277–285. https://doi.org/10.1016/j.survophthal.2016.12.005
Chan NS, Chee SP (2019) Demystifying viral anterior uveitis: a review. Clin Exp Ophthalmol 47:320–333. https://doi.org/10.1111/ceo.13417
Kandori M, Miyazaki D, Yakura K, Komatsu N, Touge C, Ishikura R, Inoue Y (2013) Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol 57:497–502. https://doi.org/10.1007/s10384-013-0268-2
Su CC, Hu FR, Wang TH, Huang JY, Yeh PT, Lin CP, Wang IJ (2014) Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol 158:1024-1031.e1022. https://doi.org/10.1016/j.ajo.2014.08.007
Chang JH, McCluskey PJ, Wakefield D (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50:364–388. https://doi.org/10.1016/j.survophthal.2005.04.003
Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI (2004) Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88:1159–1162. https://doi.org/10.1136/bjo.2003.037226
Liu X, Kelly SR, Montesano G, Bryan SR, Barry RJ, Keane PA, Denniston AK, Crabb DP (2019) Evaluating the impact of uveitis on visual field progression using large-scale real-world data. Am J Ophthalmol 207:144–150. https://doi.org/10.1016/j.ajo.2019.06.004
Jap A, Sivakumar M, Chee SP (2001) Is Posner Schlossman syndrome benign? Ophthalmology 108:913–918. https://doi.org/10.1016/s0161-6420(01)00551-6
Li J, Ang M, Cheung CM, Vania M, Chan AS, Waduthantri S, Yang H, Chee SP (2012) Aqueous cytokine changes associated with Posner-Schlossman syndrome with and without human cytomegalovirus. PLoS ONE 7:e44453. https://doi.org/10.1371/journal.pone.0044453
Ohira S, Inoue T, Iwao K, Takahashi E, Tanihara H (2016) Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma. PLoS ONE 11:e0147080. https://doi.org/10.1371/journal.pone.0147080
Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T (2014) Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol 8:2383–2389. https://doi.org/10.2147/OPTH.S72383
Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23:88–94. https://doi.org/10.1097/IJG.0b013e3182685167
Arriola-Villalobos P, Abasolo L, Garcia-Feijoo J, Fernandez-Gutierrez B, Mendez-Fernandez R, Pato E, Diaz-Valle D, Rodriguez-Rodriguez L (2018) Vision-related quality of life in patients with non-infectious uveitis: a cross-sectional study. Ocul Immunol Inflamm 26:717–725. https://doi.org/10.1080/09273948.2017.1285034
Hoeksema L, Los LI (2014) Vision-related quality of life in herpetic anterior uveitis patients. PLoS ONE 9:e85224. https://doi.org/10.1371/journal.pone.0085224
Hoeksema L, Los LI (2016) Vision-related quality of life in patients with inactive HLA-B27-associated-spectrum anterior uveitis. PLoS ONE 11:e0146956. https://doi.org/10.1371/journal.pone.0146956
Choi JA, Kim KS, Jung Y, Park HY, Park CK (2016) Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect 6:32. https://doi.org/10.1186/s12348-016-0100-5
Chee SP, Jap A (2010) Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol 94:1648–1652. https://doi.org/10.1136/bjo.2009.167767
Su CC, Wang IJ, Chen WL, Lin CP, His B, Hu FR (2013) Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty. Clin Exp Ophthalmol 41:339–347. https://doi.org/10.1111/j.1442-9071.2012.02888.x
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119:1050–1058. https://doi.org/10.1001/archopht.119.7.1050
Heo JWYH, Shin JP et al (2010) A validation and reliability study of the Korean Version of National Eye Institute Visual Function Questionnaire 25. J Korean Ophthalmol Soc 51:1354–1367
De Groot-Mijnes JDF, Chan ASY, Chee SP, Verjans G (2018) Immunopathology of virus-induced anterior uveitis. Ocul Immunol Inflamm 26:338–346. https://doi.org/10.1080/09273948.2018.1439069
Khieu C, Kongyai N, Pathanapitoon K, Van Der Eijk AA, Rothova A (2020) Causes of Hypertensive Anterior Uveitis in Thailand. Ocul Immunol Inflamm. 28:559–565. https://doi.org/10.1080/09273948.2019.1678651
Relvas LJ, Caspers L, Chee SP, Zierhut M, Willermain F (2018) Differential diagnosis of viral-induced anterior uveitis. Ocul Immunol Inflamm 26:726–731. https://doi.org/10.1080/09273948.2018.1468470
Miyanaga M, Sugita S, Shimizu N, Morio T, Miyata K, Maruyama K, Kinoshita S, Mochizuki M (2010) A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. Br J Ophthalmol 94:336–340. https://doi.org/10.1136/bjo.2008.156422
Darchuk V, Sampaolesi J, Mato L, Nicoli C, Sampaolesi R (2001) Optic nerve head behavior in Posner-Schlossman syndrome. Int Ophthalmol 23:373–379. https://doi.org/10.1023/a:1014467017300
Maruyama K, Maruyama Y, Sugita S, Mori K, Yokoyama Y, Sanuki-Kunimatsu S, Nakagawa H, Kinoshita S, Mochizuki M, Nakazawa T (2017) Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome. BMC Ophthalmol 17:45. https://doi.org/10.1186/s12886-017-0438-y
Neumann R, Barequet D, Rosenblatt A, Amer R, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Vishnevskia-Dai V, Raskin E, Blumenfeld O, Shulman S, Sanchez JM, Flores V, Habot-Wilner Z (2019) Herpetic anterior uveitis - analysis of presumed and PCR proven cases. Ocul Immunol Inflamm 27:211–218. https://doi.org/10.1080/09273948.2018.1483521
Munoz-Negrete FJ, Moreno-Montanes J, Hernandez-Martinez P, Rebolleda G (2015) Current approach in the diagnosis and management of uveitic glaucoma. Biomed Res Int 2015:742792. https://doi.org/10.1155/2015/742792
Aketa N, Yamaguchi T, Suzuki T, Higa K, Yagi-Yaguchi Y, Satake Y, Tsubota K, Shimazaki J (2017) Iris damage is associated with elevated cytokine levels in aqueous humor. Invest Ophthalmol Vis Sci 58:Bio42-bio51. https://doi.org/10.1167/iovs.17-21421
Bale JF Jr, O’Neil ME, Lyon B, Perlman S (1990) The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation. Invest Ophthalmol Vis Sci 31:1575–1581
Bale JF Jr, O’Neil ME, Folberg R (1991) Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide. Invest Ophthalmol Vis Sci 32:1749–1756
Sung VC, Barton K (2004) Management of inflammatory glaucomas. Curr Opin Ophthalmol 15:136–140. https://doi.org/10.1097/00055735-200404000-00014
Valenzuela F, Oportus MJ, Pérez CI, Mellado F, Cartes C, Villarroel F, López-Ponce D, López-Solís R, Traipe L (2018) Ahmed glaucoma drainage implant surgery in the management of refractory uveitic glaucoma: long-term follow up. Arch Soc Esp Oftalmol 93:431–438. https://doi.org/10.1016/j.oftal.2018.05.011
Voykov B, Doycheva D, Deuter C, Leitritz MA, Dimopoulos S, William A (2017) Outcomes of Ahmed glaucoma valve implantation for glaucoma secondary to Fuchs uveitis syndrome. Ocul Immunol Inflamm 25:760–766. https://doi.org/10.3109/09273948.2016.1168454
Nilforushan N, Yadgari M, Alemzadeh SA (2019) Surgical management of glaucoma in Fuchs uveitis syndrome: trabeculectomy or Ahmed glaucoma valve. J Curr Ophthalmol 31:24–30. https://doi.org/10.1016/j.joco.2018.10.005
Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472–480. https://doi.org/10.1111/ceo.12916
Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, Tube Versus Trabeculectomy Study Group (2012) Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 153:804–814. https://doi.org/10.1016/j.ajo.2011.10.024
Saheb H, Gedde SJ, Schiffman JC, Feuer WJ, Tube Versus Trabeculectomy Study Group (2014) Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study. Am J Ophthalmol 157:1179–1189
Wang Y, Zhao K, Jin Y, Niu Y, Zuo T (2003) Changes of higher order aberration with various pupil sizes in the myopic eye. J Refract Surg 19:S270-274
Hirooka K, Nitta E, Ukegawa K, Tsujikawa A (2017) Vision-related quality of life following glaucoma filtration surgery. BMC Ophthalmol 17:66. https://doi.org/10.1186/s12886-017-0466-7
Guedes RA, Guedes VM, Freitas SM, Chaoubah A (2013) Quality of life of medically versus surgically treated glaucoma patients. J Glaucoma 22:369–373. https://doi.org/10.1097/IJG.0b013e31824ceb8b
McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R (2008) Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology 115:941-948.e941. https://doi.org/10.1016/j.ophtha.2007.08.037
Cheng H, Guo C, Chen M, Ko Y, Huang N, Liu CJ (2015) Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol 133:269–275. https://doi.org/10.1001/jamaophthalmol.2014.4908
Daga FB, Gracitelli CPB, Diniz-Filho A, Medeiros FA (2019) Is vision-related quality of life impaired in patients with preperimetric glaucoma? Br J Ophthalmol 103:955–959. https://doi.org/10.1136/bjophthalmol-2018-312357
Sit AJ, Asrani S (2008) Effects of medications and surgery on intraocular pressure fluctuation. Surv Ophthalmol 53(Suppl 1):S45-55. https://doi.org/10.1016/j.survophthal.2008.08.009
The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see: http://www.textcheck.com/certificate/ebKl5n
This research was supported by National Research Foundation of Korea (NRF) (grant number 2019R1F1A1043806).
The study was conducted in accordance with the ethical standards of the Declaration of Helsinki and was approved by the Institutional Review Board of St. Vincent’s Hospital, the Catholic University, College of Medicine, which waived the written informed consent because of the study’s retrospective design.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kim, JH., Lee, JY. & Choi, J.A. Long-term prognosis for glaucoma in patients with Posner–Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol (2021). https://doi.org/10.1007/s00417-021-05291-0
- Posner–Schlossman syndrome
- Glaucoma surgery
- Vision-related quality of life